Page 419 - Feline Cardiology
P. 419

Generic Name    Indications/Drug   Dosage and   Comments                           Available sizes
               (Brand Name)    Type            Possible Routes
                                               of Admin.

               B Vitamin       Vitamin                       Unsubstantiated use for reduction of risk of
               complex         supplement                    thromboembolic disease based on identification
                                                             of lower serum vitamin B12 levels in cats with
                                                             aortic thromboembolism.
               Benazepril      Angiotensin-    0.25–0.5 mg/  Adjunctive treatment with diuretics in   5, 20 mg
               (Fortekor [V],   converting     kg PO q 24 h  congestive heart failure. Benefits of mixed   Tab VM
               Lotensin [H])   enzyme (ACE)                  renal-hepatic elimination likely of minimal   5, 10, 20, 40 mg
                               inhibitor                     clinical importance. Safe drug—anorexia,   Tab HM
                                                             sedation, hyperkalemia rare. Veterinary
                                                             formulation not available in United States.
                                                             Theoretical additional benefits (e.g., reduction
                                                             of myocardial fibrosis and hypertrophy), and
                                                             efficacy may be diminished over time (ACE
                                                             inhibitor tolerance) based on extrapolations
                                                             from other species. Possible reduction in left
                                                             ventricular thickening with chronic treatment
                                                             during compensated (“asymptomatic”) state
                                                             but unclear impact on long-term prognosis.
                                                             Minimal efficacy (if any) as single agent for
                                                             treating systemic hypertension. No significant
                                                             risk of worsening severity of left ventricular
                                                             outflow tract obstruction in HOCM due to
                                                             arteriodilation in cats.
               Betapace—see
               Sotalol
               Brethine—see
               Terbutaline
               Brevipace—see
               Esmolol
               Buprenorphine   Opiate agonist  0.005–        Sedation for echocardiography or other   0.324 mg/ml
               (Buprenex [H])                  0.01 mg/kg    noninvasive procedures; used for pain   Inj
                                               IV,IM; may be   management of acute arterial       HM
                                               given per os in   thromboembolism. Fewer respiratory center
                                               fractious cats  effects than hydromorphone. Management of
                                                             concurrent disorders (e.g., pulmonary edema,
                                                             pleural effusion) should always precede
                                                             sedation for lower risk. Higher dosage
                                                             reserved for severe pain or sedating difficult
                                                             but otherwise healthy, young cats suspected
                                                             of having mild heart disease.
               Butorphanol     Mixed opiate    0.05–0.2 mg/  Sedation for echocardiography or other   2, 10 mg/ml
               (Torbugesic [V])  agonist-      kg            noninvasive procedures. Low dose for aged,   Inj
                               antagonist      IV, IM, SQ    unstable, or otherwise compromised cats;   VM
                                                             management of concurrent disorders orders
      Drug Formulary                                         should precede sedation for lower risk. Higher
                                                             (e.g., pulmonary edema, pleural effusion)

                                                             dosage reserved for difficult but otherwise
                                                             healthy, young or middle-aged cats suspected
                                                             of having mild heart disease. May be
                                                             combined with dexmedetomidine or low-dose
                                                             acepromazine for heavy sedation. Rarely
                                                             exceed total dose 1.5 mg/cat.

              444
   414   415   416   417   418   419   420   421   422   423   424